Retinoprotective effects of Moringa oleifera via antioxidant, anti-inflammatory, and anti-angiogenic mechanisms in streptozotocin-induced diabetic rats

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 4, 2013, Pages 419-426

  Gupta, Suresh Kumar ^a   Kumar, Binit ^a   Srinivasan, B P ^a   Nag, Tapas Chandra ^b   Srivastava, Sushma ^a   Saxena, Rohit ^c   Aggarwal, Ashutosh ^a  

^a UNIVERSITY OF DELHI   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CATALASE; GLUCOSE; GLUTATHIONE; HEMOGLOBIN A1C; INTERLEUKIN 1BETA; MORINGA OLEIFERA EXTRACT; PROTEIN KINASE C BETA; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BASEMENT MEMBRANE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; MORINGA OLEIFERA; NONHUMAN; RAT; RETINA BLOOD VESSEL; RETINA FLUORESCEIN ANGIOGRAPHY; STREPTOZOCIN DIABETES; TRANSMISSION ELECTRON MICROSCOPY; VASODILATATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BASEMENT MEMBRANE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; FEMALE; INFLAMMATION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MORINGA OLEIFERA; PLANT EXTRACTS; RATS; RATS, WISTAR; RETINA; RETINAL VESSELS; STREPTOZOCIN;

EID: 84880552383     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0089     Document Type: Article

References (33)

1. Arden, G.B., and Sivaprasad, S. Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr. Diabetes Rev. 7:291-304, 2011.
2. Kumar, B., Gupta, S.K., Nag, T.C., Srivastava, S., and Saxena, R. Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats. Ophthalmic. Res. 47:103-108, 2012.
3. Kumar, B.,Gupta, S.K., Srinivasan, B. P., Nag, T.C., Srivastava, S., Saxena, R. Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats. Vascul. Pharmacol. 57:201-207, 2012.
4. Wang, J., Xu, X., Elliott, M.H., and Le, Y.Z. Mu ller cellderived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 59:2297-2305, 2010.
5. Gupta, R., Mathur, M., Katariya, P., Yadav, S., Kamal, R., and Gupta, R.S. Evaluation of antidiabetic and antioxidant activity of Moringa oleifera in experimental diabetes. J. Diabetes. 4:164-171, 2012.
6. Muangnoi, C., Chingsuwanrote, P., Praengamthanachoti, P., Svasti, S., and Tuntipopipat, S. Moringa oleifera pod inhibits inflammatory mediator production by lipopolysaccharidestimulated RAW 264.7 murine macrophage cell lines. Inflammation 35:445-455, 2012.
7. Adisakwattana, S., and Chanathong, B. Alpha-glucosidase inhibitory activity and lipid-lowering mechanisms of Moringa oleifera leaf extract. Eur. Rev. Med. Pharmacol. Sci. 15:803-808, 2011.
8. Gupta, S.K., Kumar, B., Nag, T.C., et al. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J. Ocul. Pharmacol. Ther. 27:123-130, 2011.
9. Kowalczuk, L., Touchard, E., Omri, S., et al. Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. PLoS One 6:e17462, 2011.
10. Lowry, O.H., Rosenbrough, N.J., Farr, A.L., and Randall, R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193:265-275, 1951.
11. Tsai, A.S., Wong, T.Y., Lavanya, R., et al. Differential association of retinal arteriolar and venular caliber with diabetes and retinopathy. Diabetes Res. Clin. Pract. 94:291-298, 2011.
12. Sasongko, M.B., Wong, T.Y., Donaghue, K.C., et al. Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes. Am. J. Ophthalmol. 53:176-183.e1, 2012.
13. Cai, J., and Boulton, M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye 16:242-260, 2002.
14. Kamalakkannan, N., and Prince, P.S. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin. Pharmacol. Toxicol. 98:97-103, 2006.
15. Sreelatha, S., and Padma, P.R. Modulatory effects of Moringa oleifera extracts against hydrogen peroxide-induced cytotoxicity and oxidative damage. Hum. Exp. Toxicol. 30:1359-1368, 2011.
16. Sasikala, V., Rooban, B.N., Priya, S.G., Sahasranamam, V., and Abraham, A. Moringa oleifera prevents seleniteinduced cataractogenesis in rat pups. J. Ocul. Pharmacol. Ther. 26:441-447, 2010.
17. Fakurazi, S., Hairuszah, I., and Nanthini, U. Moringa oleifera Lam prevents acetaminophen induced liver injury through restoration of glutathione level. Food Chem. Toxicol. 46:2611-2615, 2008.
18. Suzuki, Y., Nakazawa, M., Suzuki, K., Yamazaki, H., and Miyagawa, Y. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn. J. Ophthalmol. 55:256-263, 2011.
19. Doganay, S., Evereklioglu, C., Er, H., et al. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16:163-170, 2002.
20. Mahajan, S.G., Mali, R.G., and Mehta, A.A. Protective Effect of Ethanolic Extract of Seeds of Moringa oleifera Lam. Against inflammation associated with development of arthritis in rats. J. Immunotoxicol. 4:39-47, 2007.
21. Adamis, A.P., Miller, J.W., Bernal, M.T., et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118:445-450, 1994.
22. Miyamoto, K., Khosrof, S., Bursell, S.E., et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am. J. Pathol. 156:1733-1739, 2000.
23. Waisbourd, M., Goldstein, M., and Loewenstein, A. Treatment of diabetic retinopathy with anti-VEGF drugs. Acta Ophthalmol. 89:203-207, 2011.
24. Aiello, L.P., Bursell, S.E., Clermont, A., et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46: 1473-1480, 1997.
25. Xu, X., Zhu, Q., Xia, X., Zhang S, Gu, Q., and Luo, D. Bloodretinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats. Curr. Eye Res. 28:251-256, 2004.
26. Harhaj, N.S., Felinski, E.A., Wolpert, E.B., Sundstrom, J.M., Gardner, T.W., and Antonetti, D.A. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest. Ophthalmol. Vis. Sci. 47:5106-5115, 2006.
27. Chen, Y., Li, X.X., Xing, N.Z., and Cao, X.G. Quercetin inhibits choroidal and retinal angiogenesis in vitro. Graefes Arch. Clin. Exp. Ophthalmol. 246:373-378, 2008.
28. Fan, P.S., Gu, Z.L., Sheng, R., Liang, Z.Q., Wang, X.X., and Zhu, Y. Inhibitory effect of quercetin on proliferation of human microvascular endothelial cells in vitro. Acta Pharmacol. Sinica. 24:1231-1234, 2003.
29. Chronopoulos, A., Trudeau, K., Roy, S., Huang, H., Vinores, S.A., and Roy, S. High glucose-induced altered basement membrane composition and structure increases transendothelial permeability: implications for diabetic retinopathy. Curr. Eye Res. 2011:36:747-753.
30. Roy, S., Sato, T., Paryani, G., and Kao, R. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 52:1229-1234, 2003.
31. Tsilibary, E.C. Microvascular basement membranes in diabetes mellitus. J. Pathol. 200:537-546, 2003.
32. Geraldes, P., and King, G.L. Activation of protein kinase C isoforms and its impact on diabetic complications. Cir. Res. 106:1319-1331, 2010.
33. Roy, S., Ha, J., Trudeau, K., and Beglova, E. Vascular basement membrane thickening in diabetic retinopathy. Curr. Eye Res. 35:1045-1056, 2010.